THE SMART TRICK OF AZELAPRAG PEPTIDE THAT NO ONE IS DISCUSSING

In December, BioAge introduced a multi-yr study collaboration with Novartis to determine and validate novel therapeutic targets in the intersection of aging biology and exercise, combining BioAge's longitudinal human getting old datasets with Novartis know-how in training biology.For MASH builders, a race for hard cash: Akero Therapeutics aims to l